August 2015 FDA Recall Drug by Akorn, Inc.
D-0231-2016 - Failed Impurity/Degradation Specifications

This Class III drug recall was voluntarily initiated by Akorn, Inc. on August 20, 2015 for the product Drug. The FDA reported the reason for recall as failed impurity/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0231-2016

Reason for Recall
Failed Impurity/Degradation Specifications: Out of Specifications result obtained for a known impurity.
Initiated
08-20-2015
Reported
11-25-2015
Quantity
6861 Vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
72192
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Akorn, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
US: Nationwide
Termination Date About Termination Date
Date that FDA officially terminated the recall.
01-26-2017
Product Description About Product Description
Full technical description of the product.
RIFAMPIN FOR INJECTION USP, 600 mg*/vial, Rx Only. Mfd. for: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-151-42.

Batch or Lot Expiration Information

Lot# : 14RIF1(A), Expiry: 9/30/2016.